NLS Pharmaceutics Ltd (NASDAQ:NLSP) has a beta value of -0.52 and has seen 9.88 million shares traded in the recent trading session. The company, currently valued at $10.25M, closed the recent trade at $4.18 per share which meant it gained $0.58 on the day or 16.11% during that session. The NLSP stock price is -598.56% off its 52-week high price of $29.20 and 16.03% above the 52-week low of $3.51. If we look at the company’s 10-day average daily trading volume, we find that it stood at 23910.0 shares traded. The 3-month trading volume is 21.46K shares.
The consensus among analysts is that NLS Pharmaceutics Ltd (NLSP) is Buy stock at the moment, with a recommendation rating of 3.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
NLS Pharmaceutics Ltd (NASDAQ:NLSP) trade information
Sporting 16.11% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the NLSP stock price touched $4.18 or saw a rise of 11.81%. Year-to-date, NLS Pharmaceutics Ltd shares have moved -82.29%, while the 5-day performance has seen it change 1.70%. Over the past 30 days, the shares of NLS Pharmaceutics Ltd (NASDAQ:NLSP) have changed -14.69%. Short interest in the company has seen 51746.0 shares shorted with days to cover at 1.64.
NLS Pharmaceutics Ltd (NLSP) estimates and forecasts
The company’s shares have lost -23.16% over the past 6 months. If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 7.15% over the past 5 years.
NLSP Dividends
NLS Pharmaceutics Ltd is expected to release its next earnings report in December this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
NLS Pharmaceutics Ltd (NASDAQ:NLSP)’s Major holders
The top two institutional holders are BVF INC/IL with over 5.75 million shares worth more than $1.25 million. As of 2024-06-30, BVF INC/IL held 15.0543% of shares outstanding.
The other major institutional holder is ARMISTICE CAPITAL, LLC, with the holding of over 2.31 million shares as of 2024-06-30. The firm’s total holdings are worth over $0.5 million and represent 6.0535% of shares outstanding.
